Sudden Death in Children Treated with a Tricyclic Antidepressant
- 1 May 1991
- journal article
- research article
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 30 (3) , 495-498
- https://doi.org/10.1097/00004583-199105000-00023
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- A Double-blind Placebo Controlled Study of Desipramine in the Treatment of ADD: II. Serum Drug Levels and Cardiovascular FindingsJournal of the American Academy of Child & Adolescent Psychiatry, 1989
- A Double-Blind Placebo Controlled Study of Desipramine in the Treatment of ADD: I. EfficacyJournal of the American Academy of Child & Adolescent Psychiatry, 1989
- Cardiovascular effects of desipramine in children and adolescents with attention deficit disorderThe Journal of Pediatrics, 1985
- Plasma levels of imipramine and adverse effects in childrenAmerican Journal of Psychiatry, 1983
- Pharmacokinetics of psychotropic drugs: What can it tell us?Progress in Neuro-Psychopharmacology and Biological Psychiatry, 1982
- Cardiovascular Effects of Therapeutic Doses of Tricyclic AntidepressantsArchives of General Psychiatry, 1981
- Plasma Levels of Imipramine (IMI) and Desmethylimipramine (DMI) and Clinical Response in Prepubertal Major Depressive Disorder: A Preliminary ReportJournal of the American Academy of Child Psychiatry, 1979
- Effects of several tricyclic antidepressants on the hemodynamics and myocardial contractility of the anesthetized dogsEuropean Journal of Pharmacology, 1977
- Controlled Imipramine Treatment of School PhobiaArchives of General Psychiatry, 1971
- AMITRIPTYLINE AND CARDIAC DISEASE: Risk of Sudden Death Identified by Monitoring SystemThe Lancet, 1970